CALL FOR ABSTRACTS


IMMUNOTHERAPY BRIDGE
December 2nd-3rd, 2020


*******THE CALL FOR ABSTRACT IS NOW OPEN***

Immunotherapy Bridge Presidents are glad to invite the submission of abstracts for the presentation of oral communications and posters at next meeting held from December 2nd to December 3rd

The themes of oral and poster presentation are:

  • SITC Session - Biomarkers
  • Trends in Immunotherapy
  • Drivers of immune responses
  • Neo Adjuvant in different types of cancer
  • Great Debate on
    • Antitumoral vaccination is still an option: yes or not?
    • Is anti PD-1 / PDL1 a backbone for immunotherapy combination: yes or not?
    • Do we need an innovative studies design and is overall survival the endpoint? Point of view of Academia, point of view of Company, point of view "regulatory"
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the Immunotherapy Bridge Congress.

The accepted abstract which have not been published elsewhere will be included in a dedicated Supplement of the Journal of Translational Medicine.

Important Dates for Abstracts Submission:

Submission opening: May 15th, 2020
Submission deadline: September 23rd, 2020

Notification: September 30th, 2020


Submission Guidelines

Submit your abstract as word file by e-mail to abstract@melanomabridge.org

Receipt of your abstract will be acknowledged by e-mail within a few days. If acknowledgement is not received within one week of submission, please contact us again.

Guidelines for authors

Please find an example abstract here

For information please contact abstract@melanomabridge.org